Pembrolizumab vs Simvastatin
Pembrolizumab vs Simvastatin: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Simvastatin.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Simvastatin — 2 hours.
Chemical Properties
Molecular Formula: Simvastatin — C25H38O5.
Molecular Weight: Simvastatin — 418.5700 g/mol.
Type: Pembrolizumab — Antibody; Simvastatin — Small molecule.